The 3 references without contexts in paper D. Plotnikov M., K. Burkova I., L. Alexeyevа N., M. Azhermacheva N., N. Pugachenko V., N. Zautner A., T. Valikova A., V. Alifirova M., В. Алифирова М., Д. Плотников М., К. Буркова И., Л. Алексеева Н., М. Ажермачева Н., Н. Заутнер А., Н. Пугаченко В., Т. Валикова А. (2015) “БОЛЕЗНЬ МОЯ-МОЯ (клиническое наблюдение) // MOYA-MOYA DISEASE (CLINICAL CASE)” / spz:neicon:nevro:y:2014:i:5:p:38-42

9
Chiu D., Shedden P., bratina P., grotta J.C. Clinical features of moyamoya disease in the United States. Stroke. 1998; 29: 1347– 51.
(check this in PDF content)
10
feole J.В., Ah A., fordham e.w . et al. Serial SPeCT imaging in moyamoya using 1–123 IMP. A method of noninvasive evaluation and follow-up. Clin. Nucl. Med. 1993; 18(1): 43–5.
(check this in PDF content)
19
3; 14: 104–9. 18. wakai K., Tamakoshi A., Ikezaki K. et. al. epidemiological features of moyamoya disease in Japan: findings from nationwide survey. Clin. Neurol. Neurosurg. 1997; 99: (Suppl. 2): 1–5.
(check this in PDF content)